Authors
Loading...
This research demonstrates the in silico development of pyruvic acid derivatives targeting COX-2, suggesting potential analgesic and anti-inflammatory benefits.
Aryadi Kurniawan (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: